Frontier Space Technologies

Frontier Space Technologies develops autonomous laboratory systems for conducting pharmaceutical research and biomanufacturing in microgravity. Founded in 2021 as a spinout from Cranfield University, the company builds SpaceLab, a modular, autonomous lab-in-a-box designed to support in-orbit experiments including protein crystallography, cell culture, and precision fermentation. The company also develops a larger bioreactor platform for on-orbit manufacturing of high-value bioproducts. Frontier Space offers end-to-end microgravity research services with custom sample containers, microfluidics chips, onboard imaging, environmental monitoring, and active thermal management. The company has flown two EGGS (Early Gen micro-Gravity Service) missions: EGGS-1 aboard a SpaceX Falcon 9 in April 2025 as part of an ESA-funded project, and EGGS-2 on PSLV-C62 in January 2026 in partnership with Azenta Life Sciences and Orbital Paradigm. Headquartered at the Medical Technologies Innovation Facility at Nottingham Trent University, with a second facility at Space Park Leicester, the company serves pharmaceutical and life sciences customers seeking to leverage microgravity for drug discovery and bioprocessing.